Patents Assigned to Lemmon Company
  • Patent number: 4341783
    Abstract: Dyphylline is used preferably as the active ingredient in a cream base for topical application to the skin in the treatment of psoriasis and atopic dermatitis. The invention involves the method of use of dyphylline, as well as dyphylline containing compositions.
    Type: Grant
    Filed: July 31, 1980
    Date of Patent: July 27, 1982
    Assignee: Lemmon Company
    Inventor: Stanley Scheindlin